Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 2.73 | 16.33 |
| PEG Ratio (TTM) | 1.06 | 1.76 |
| P/S Ratio (TTM) | 1.14 | 2.63 |
| P/B Ratio (TTM) | 0.40 | 1.94 |
| P/FCF Ratio (TTM) | 380.01 | 11.09 |
| Price to 5YR AVG Earnings Ratio | 2.25 | 14.01 |
| Price to 5YR AVG FCF Ratio | 16.61 | 7.98 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.21% | 1,447.98% |
| ROE (TTM) | 15.24% | 8.98% |
| Net Profit Margin (TTM) | 19.85% | 15.68% |
| ROIC 5YR AVG | 22.19% | 20.29% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 11.32% | -33.33% | -31.57% |
| Revenue | -10.31% | -23.17% | 67.18% |
| Net Income | 10.80% | 12.49% | 50.37% |
| Cash Flow | 20.38% | 28.30% | 119,787,812.08% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 15.77 | 3.31 |
| Quick Ratio (TTM) | 97.46 | 5.14 |
| D/E Ratio (TTM) | 0.77 | 1.29 |
| Interest Coverage (TTM) | 1.59 | 0.64 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.44 | 0.38 |
| LTL to 5YR AVG FCF | 17.03 | 6.34 |
| Shares Outstanding Growth 5YR AVG | -20.73% | 4.96% |